Appetite Suppressants in 2025: How They Work and Who Should Use Them
In 2025, appetite suppressants are among the most popular tools for managing obesity and achieving sustainable weight loss. These medications work by targeting brain receptors that regulate hunger and fullness, helping users reduce caloric intake without constant cravings.
Modern appetite suppressants are primarily based on GLP-1 receptor agonists like Ozempic or semaglutide. These weekly injections not only reduce appetite but also help stabilize blood sugar levels. Many patients report dramatic results within 12 to 16 weeks. Read more in our semaglutide breakdown.
For those who prefer daily treatments, options like liraglutide (Saxenda) remain widely used. Although slightly less effective in some studies, they’re ideal for patients who want a more traditional protocol. Learn how it compares in our liraglutide guide.
It's important to note that not everyone is a candidate for appetite suppressants. Individuals with a history of thyroid cancer or severe gastrointestinal conditions should avoid GLP-1 drugs. Always consult a licensed physician before beginning any medication-based weight loss program.
Who Should Use Appetite Suppressants?
- Patients with a BMI over 30, or over 27 with health conditions
- People who’ve struggled with diet and exercise alone
- Those seeking medically supervised, FDA-approved treatments